Kurek, Ralf <br/><br/>
Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2004 
 - 5808-14 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-1004-03  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Surface--blood<br/>Case-Control Studies<br/>DNA, Complementary--genetics<br/>Glutamate Carboxypeptidase II--blood<br/>Humans<br/>Lymph Nodes--metabolism<br/>Male<br/>Neoplasm Staging<br/>Prognosis<br/>Prostate--metabolism<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>RNA, Messenger--blood<br/>RNA, Neoplasm--blood<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sensitivity and Specificity<br/>Tissue Kallikreins--blood<br/>Tumor Cells, Cultured